Join Emre Isin (UCB) and Martin Hayes (AstraZeneca) to hear their reasoning behind, and experience of, creating organizational value from metabolite identification data; from the initial build of a metabolite database in 2008 at AstraZeneca to a more recent deployment at UCB.